Hancock Jaffe Laboratories, Inc

(NASDAQ:HJLI)

Latest On Hancock Jaffe Laboratories, Inc (HJLI):

Date/Time Type Description Signal Details
2021-09-21 20:19 ESTNewsHancock Jaffe to change name and narrow strategic focusN/A
2021-09-09 05:47 ESTNewsHancock Jaffe Laboratories: Developing Nature-Mimetic BioprostheticsN/A
2021-08-03 12:42 ESTNewsHancock Jaffe (HJLI) stock jumps 40% on Breakthrough Device tag for VenoValveN/A
2021-07-21 11:07 ESTNewsHancock Jaffe Laboratories <> presents at HealthVirtual Conference - slideshowN/A
2021-04-06 04:02 ESTNewsHancock Jaffe shares rise after IDE approval to begin venovalve U.S. pivotal trialN/A
2021-02-15 07:46 ESTAnalyst RatingThe Analyst Target Price has increased from $26.25 to $28.Buy
2020-12-31 16:57 ESTNewsHancock Jaffe Laboratories finance chief sheds interim tagN/A
2020-12-02 12:10 ESTAnalyst RatingThe Analyst Target Price has decreased from $52.5 to $26.25.Neutral
2020-12-01 20:13 ESTAnalyst RatingThe Analyst Target Price has increased from $2.1 to $52.5.Buy
2020-12-01 12:09 ESTStock SplitA stock split has occured on Nov 30, 2020 with a split factor of 1:25.Neutral
2020-11-27 22:57 ESTNewsHancock Jaffe approves 1:25 reverse stock splitN/A
2020-11-26 20:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 12:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 12:13 ESTEarnings EstimateAn EPS average of -$0.14 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-07 16:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 12:59 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:06 ESTFinancialsCompany financials have been released.Neutral
2020-09-04 04:47 ESTAnalyst RatingThe Analyst Target Price has decreased from $3 to $2.1.Neutral
2020-08-16 08:52 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:03 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 14:11 ESTNewsHancock Jaffe regains Nasdaq complianceN/A
2020-08-06 20:57 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-21 22:06 ESTInsider TradeRobert Gray has directly acquired 62,500 shares and currently holds 78,250 shares.Buy
2020-07-21 22:06 ESTInsider TradeFrancis Duhay has directly acquired 62,500 shares and currently holds 107,228 shares.Buy
2020-07-21 22:06 ESTInsider TradeSanjay Shrivastava has directly acquired 62,500 shares and currently holds 97,500 shares.Buy
2020-07-17 19:43 ESTNewsHancock Jaffe Laboratories prices $5.6M offeringN/A
2020-07-09 08:57 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 08:56 ESTFinancialsCompany financials have been released.Neutral
2020-06-13 00:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 04:59 ESTFinancialsCompany financials have been released.Neutral
2020-06-08 15:15 ESTInsider TradeBiodyne Holding, S.A. has directly disposed of 1,683 shares and currently holds 3,355,433 shares.Sell
2020-06-08 15:15 ESTInsider TradeBiodyne Holding, S.A. has directly disposed of 3,900 shares and currently holds 3,357,116 shares.Sell
2020-06-08 15:15 ESTInsider TradeBiodyne Holding, S.A. has directly disposed of 220,000 shares and currently holds 3,361,016 shares.Sell
2020-06-02 01:45 ESTNewsHancock Jaffe Laboratories +24% on direct offering priced at the marketN/A
2020-05-27 05:04 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 09:54 ESTInsider TradeBiodyne Holding, S.A. has directly disposed of 684,813 shares and currently holds 3,581,016 shares.Sell
2020-05-06 05:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 09:04 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 00:55 ESTFinancialsCompany financials have been released.Neutral
2020-03-22 00:52 ESTFinancialsCompany financials have been released.Neutral
2020-03-20 00:46 ESTEarnings EstimateAn EPS average of -$0.50 is estimated for the 2021 year.Sell
2020-02-28 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 20:45 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 23:49 ESTFinancialsCompany financials have been released.Neutral
2020-02-12 23:49 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 23:55 ESTFinancialsCompany financials have been released.Neutral
2020-01-31 23:52 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 23:52 ESTFinancialsCompany financials have been released.Neutral

About Hancock Jaffe Laboratories, Inc (HJLI):

Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It develops and manufactures bioprosthetic implantable devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. operates as a subsidiary of Leman Cardiovascular SA.

HJLI Quotes by TradingView

See Advanced Chart

General

  • Name Hancock Jaffe Laboratories, Inc
  • Symbol HJLI
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 12
  • Last Split Factor1:25
  • Last Split Date2020-11-30
  • Fiscal Year EndDecember
  • IPO Date2018-05-31
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.hancockjaffe.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 216.91
  • Price/Book (Most Recent Quarter) 12.72
  • Enterprise Value Revenue 159.37
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Return on Assets -65%
  • Return on Equity -179%
  • Earnings Per Share -$0.54
  • Revenue Per Share $0
  • Gross Profit -2174877
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 61.23 million
  • EBITDA -6392252
  • Analyst Target Price $28
  • Book Value Per Share $2.98
View More

Share Statistics

  • Shares Outstanding 8.5 million
  • Shares Float 1.71 million
  • % Held by Insiders 525%
  • % Held by Institutions 6.67%
  • Shares Short 219926
  • Shares Short Prior Month 164029
  • Short Ratio 0.2
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.53
  • 52 Week High $15
  • 52 Week Low $5.28
  • 50 Day Moving Average 7.83
  • 200 Day Moving Average 8.88
View More

Dividends

  • Dividend Date 2020-11-30
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Hancock Jaffe Laboratories, Inc (HJLI) Dividend Calendar:

HJLI's last dividend payment was made to shareholders on November 30, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Hancock Jaffe Laboratories, Inc (HJLI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-06$N/A-$2.00-$1.25-60%
2020-06-302020-08-14$N/A-$0.08
2020-03-312020-06-08$N/A-$0.06
2019-12-312020-03-18$N/A-$3.25-$3.250%
2019-09-302019-10-31$N/A-$2.50-$3.5028.57%
2019-06-302019-08-05$N/A-$3.25
2019-03-312019-06-13$31243-$0.13
2018-12-312019-02-27$30462-$3.80
2018-09-302018-11-28$41662-$3.13
2018-06-302018-08-29$83363-$26.43

Hancock Jaffe Laboratories, Inc (HJLI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A N/A 2.21 million N/A
Income Before Tax N/A N/A N/A -2.29 million -1.81 million
Selling General Administrative N/A N/A N/A 922339 1.16 million
Gross Profit N/A N/A N/A 1.42 million -676970
Ebit N/A N/A N/A -1.71 million -1.83 million
Operating Income N/A N/A N/A -1.71 million -1.83 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A -1.42 million 676970
Total Other Income Expense Net N/A N/A N/A -580587 19139
Net Income From Continuing Operations N/A N/A N/A -2.29 million -1.81 million
Net Income Applicable to Common Shares -1.95 million -1.63 million -1.16 million -2.29 million -1.81 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities -593127 169550 176617 9862 14434
Total Cash Flow from Investing Activities -24965 -122473 -5313 -12957 -171904
Net Borrowings N/A 312700 N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A N/A N/A
Change to Operating Activities -369756 -84720 -39810 -232832 152543
Change in Cash N/A N/A N/A -1.64 million -1.52 million
Total Cash from Operating Activities -2.59 million -1.32 million -1.15 million -1.62 million -1.35 million
Depreciation N/A N/A N/A 104987 103966
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities 439594 79568 -79568 935784 N/A
Change to Net Income 247466 118993 -215239 785515 193929
Capital Expenditures N/A N/A N/A 12957 171904
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A N/A 2.44 million 2.67 million
Total Stockholder Equity N/A N/A N/A 989940 3.08 million
Other Current Liabilities 33000 N/A N/A 33000 33000
Total Assets N/A N/A N/A 3.43 million 5.75 million
Common Stock 403 240 192 179 179
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -60.95 million -58.97 million -57.35 million -56.19 million -53.9 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 29843 839898 839898 839898 839898
Cash N/A N/A N/A 1.31 million 2.94 million
Total Current Liabilities 1.92 million N/A N/A 1.88 million 2.02 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 1.04 million 1.11 million 1.09 million 1.17 million 1.24 million
Total Current Assets 5.98 million N/A N/A 1.42 million 3.06 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 4.79 million 369445 -14623 989940 2.48 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 974229 N/A N/A 1.22 million 1.21 million

Hancock Jaffe Laboratories, Inc (HJLI) Chart:

Hancock Jaffe Laboratories, Inc (HJLI) News:

Below you will find a list of latest news for Hancock Jaffe Laboratories, Inc (HJLI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Hancock Jaffe Laboratories, Inc (HJLI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Hancock Jaffe Laboratories, Inc (HJLI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220012514/0001493152-20-012514-index.htm
2018-06-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000018018646/0000000000-18-018646-index.htm
2019-05-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000019008730/0000000000-19-008730-index.htm
2019-05-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000019009019/0000000000-19-009019-index.htm
2020-04-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000020003210/0000000000-20-003210-index.htm
2020-06-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000020005484/0000000000-20-005484-index.htm
2020-07-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000020006136/0000000000-20-006136-index.htm
2020-08-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000020007256/0000000000-20-007256-index.htm
2020-08-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661053/000000000020007433/0000000000-20-007433-index.htm
2020-10-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000090266420003630/0000902664-20-003630-index.htm
2018-06-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000110465918040399/0001104659-18-040399-index.htm
2018-12-26SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000110465918074595/0001104659-18-074595-index.htm
2018-10-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000121390018013846/0001213900-18-013846-index.htm
2018-10-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000121390018013850/0001213900-18-013850-index.htm
2020-06-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000121390020014700/0001213900-20-014700-index.htm
2020-07-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000121390020019277/0001213900-20-019277-index.htm
2019-04-16DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000146581819000021/0001465818-19-000021-index.htm
2019-05-03D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000146581819000024/0001465818-19-000024-index.htm
2020-03-10DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000146581820000008/0001465818-20-000008-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008013/0001493152-18-008013-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008014/0001493152-18-008014-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008015/0001493152-18-008015-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008016/0001493152-18-008016-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008017/0001493152-18-008017-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008018/0001493152-18-008018-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008019/0001493152-18-008019-index.htm
2018-05-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008020/0001493152-18-008020-index.htm
2018-05-31S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1661053/000149315218008031/0001493152-18-008031-index.htm
2018-06-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1661053/000149315218008137/0001493152-18-008137-index.htm
2018-06-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1661053/000149315218008138/0001493152-18-008138-index.htm
2018-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008288/0001493152-18-008288-index.htm
2018-06-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008505/0001493152-18-008505-index.htm
2018-06-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315218008510/0001493152-18-008510-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008687/0001493152-18-008687-index.htm
2018-06-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315218008849/0001493152-18-008849-index.htm
2018-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315218010296/0001493152-18-010296-index.htm
2018-07-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218010482/0001493152-18-010482-index.htm
2018-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315218011393/0001493152-18-011393-index.htm
2018-08-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218011420/0001493152-18-011420-index.htm
2018-08-17144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218012213/0001493152-18-012213-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218013747/0001493152-18-013747-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315218013981/0001493152-18-013981-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315218015351/0001493152-18-015351-index.htm
2018-11-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218016821/0001493152-18-016821-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218016878/0001493152-18-016878-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218016879/0001493152-18-016879-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218016880/0001493152-18-016880-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218017031/0001493152-18-017031-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315218017034/0001493152-18-017034-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315218017846/0001493152-18-017846-index.htm
2019-02-143/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219002123/0001493152-19-002123-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219002124/0001493152-19-002124-index.htm
2019-02-143/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219002125/0001493152-19-002125-index.htm
2019-02-143/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219002126/0001493152-19-002126-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219003239/0001493152-19-003239-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661053/000149315219003283/0001493152-19-003283-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219003384/0001493152-19-003384-index.htm
2019-03-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315219004206/0001493152-19-004206-index.htm
2019-04-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219005579/0001493152-19-005579-index.htm
2019-04-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315219005917/0001493152-19-005917-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219006125/0001493152-19-006125-index.htm
2019-05-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1661053/000149315219006213/0001493152-19-006213-index.htm
2019-05-07424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1661053/000149315219006521/0001493152-19-006521-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315219006722/0001493152-19-006722-index.htm
2019-05-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661053/000149315219007174/0001493152-19-007174-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219008204/0001493152-19-008204-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219008257/0001493152-19-008257-index.htm
2019-05-30144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219008379/0001493152-19-008379-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219008836/0001493152-19-008836-index.htm
2019-06-07S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315219008890/0001493152-19-008890-index.htm
2019-06-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315219008923/0001493152-19-008923-index.htm
2019-06-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1661053/000149315219009147/0001493152-19-009147-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219011190/0001493152-19-011190-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219011362/0001493152-19-011362-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219011515/0001493152-19-011515-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315219011628/0001493152-19-011628-index.htm
2019-08-05144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219011634/0001493152-19-011634-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219014220/0001493152-19-014220-index.htm
2019-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219014578/0001493152-19-014578-index.htm
2019-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219014616/0001493152-19-014616-index.htm
2019-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219015687/0001493152-19-015687-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219015944/0001493152-19-015944-index.htm
2019-10-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219016063/0001493152-19-016063-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315219016299/0001493152-19-016299-index.htm
2019-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315219016545/0001493152-19-016545-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315219019026/0001493152-19-019026-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220003227/0001493152-20-003227-index.htm
2020-03-05144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220003382/0001493152-20-003382-index.htm
2020-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661053/000149315220004260/0001493152-20-004260-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220004719/0001493152-20-004719-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220005744/0001493152-20-005744-index.htm
2020-04-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220005997/0001493152-20-005997-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220006195/0001493152-20-006195-index.htm
2020-04-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315220006434/0001493152-20-006434-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220006764/0001493152-20-006764-index.htm
2020-04-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661053/000149315220007189/0001493152-20-007189-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220007190/0001493152-20-007190-index.htm
2020-05-08144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220007985/0001493152-20-007985-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220008635/0001493152-20-008635-index.htm
2020-05-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220008636/0001493152-20-008636-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220009173/0001493152-20-009173-index.htm
2020-06-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661053/000149315220010420/0001493152-20-010420-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220010423/0001493152-20-010423-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/0001493152-20-010731-index.htm
2020-06-08144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220010733/0001493152-20-010733-index.htm
2020-06-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315220010767/0001493152-20-010767-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220011196/0001493152-20-011196-index.htm
2020-06-15S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220011201/0001493152-20-011201-index.htm
2020-06-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315220011591/0001493152-20-011591-index.htm
2020-07-02S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220012514/0001493152-20-012514-index.htm
2020-07-09144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220012986/0001493152-20-012986-index.htm
2020-07-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220013174/0001493152-20-013174-index.htm
2020-07-13FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013201/0001493152-20-013201-index.htm
2020-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013315/0001493152-20-013315-index.htm
2020-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013317/0001493152-20-013317-index.htm
2020-07-16S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220013425/0001493152-20-013425-index.htm
2020-07-20424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1661053/000149315220013579/0001493152-20-013579-index.htm
2020-07-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013724/0001493152-20-013724-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013748/0001493152-20-013748-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013751/0001493152-20-013751-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013752/0001493152-20-013752-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013753/0001493152-20-013753-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013754/0001493152-20-013754-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013755/0001493152-20-013755-index.htm
2020-07-24PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220013916/0001493152-20-013916-index.htm
2020-08-04DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220014591/0001493152-20-014591-index.htm
2020-08-07144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220014950/0001493152-20-014950-index.htm
2020-08-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661053/000149315220015108/0001493152-20-015108-index.htm
2020-08-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220015332/0001493152-20-015332-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661053/000149315220015611/0001493152-20-015611-index.htm
2020-08-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1661053/000149315220016238/0001493152-20-016238-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220017913/0001493152-20-017913-index.htm
2020-09-17S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220017964/0001493152-20-017964-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/0001493152-20-018750-index.htm
2020-10-05S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220018951/0001493152-20-018951-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661053/000149315220019173/0001493152-20-019173-index.htm
2020-10-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661053/000149315220019175/0001493152-20-019175-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220019736/0001493152-20-019736-index.htm
2020-10-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661053/000149315220019737/0001493152-20-019737-index.htm
2020-11-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661053/000149315220020711/0001493152-20-020711-index.htm
2018-05-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999518001373/9999999995-18-001373-index.htm
2018-06-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999518001563/9999999995-18-001563-index.htm
2019-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999519000899/9999999995-19-000899-index.htm
2019-05-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999519001013/9999999995-19-001013-index.htm
2019-06-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999519001330/9999999995-19-001330-index.htm
2020-04-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999520000777/9999999995-20-000777-index.htm
2020-06-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999520001515/9999999995-20-001515-index.htm
2020-07-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999520001833/9999999995-20-001833-index.htm
2020-10-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661053/999999999520002945/9999999995-20-002945-index.htm

Hancock Jaffe Laboratories, Inc (HJLI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hancock Jaffe Laboratories, Inc (HJLI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 525%
Institutional Ownership: 667%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-18Francis DuhayDirectorBuy62,500.00107,228.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220013753/0001493152-20-013753-index.htm
2019-03-12ROBERT ANDREW BERMANChief Executive OfficerBuy21,740.001.1525,001.0021,740.00https://www.sec.gov/Archives/edgar/data/1661053/000149315219003384/0001493152-19-003384-index.htm
2018-11-27Francis DuhayDirectorBuy29,183.002.5775,000.3129,183.00https://www.sec.gov/Archives/edgar/data/1661053/000149315218017034/0001493152-18-017034-index.htm
2018-11-27Marcus W. RobinsDirectorBuy29,183.002.5775,000.3129,183.00https://www.sec.gov/Archives/edgar/data/1661053/000149315218016880/0001493152-18-016880-index.htm
2018-11-27Sanjay ShrivastavaDirectorBuy29,183.002.5775,000.3129,183.00https://www.sec.gov/Archives/edgar/data/1661053/000149315218016879/0001493152-18-016879-index.htm
2020-06-03Biodyne Holding, S.A.10% Share HolderSell1,683.000.31521.733,355,433.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/0001493152-20-010731-index.htm
2020-06-03Biodyne Holding, S.A.10% Share HolderSell3,900.000.311,209.003,357,116.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/0001493152-20-010731-index.htm
2020-06-02Biodyne Holding, S.A.10% Share HolderSell220,000.000.3372,600.003,361,016.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220010731/0001493152-20-010731-index.htm
2019-06-07Biodyne Holding, S.A.10% Share HolderSell684,813.000.67458,824.713,581,016.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220008635/0001493152-20-008635-index.htm
2018-11-27Benedict BroennimannChief Medical Officer, OUSBuy3,334.00437,778.00https://www.sec.gov/Archives/edgar/data/1661053/000149315218016878/0001493152-18-016878-index.htm
2020-07-18Robert GrayDirectorBuy62,500.0078,250.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220013752/0001493152-20-013752-index.htm
2020-07-18Sanjay ShrivastavaDirectorBuy62,500.0097,500.00https://www.sec.gov/Archives/edgar/data/1661053/000149315220013754/0001493152-20-013754-index.htm